François Lucia1,2, Dimitris Visvikis3, Martin Vallières3, Marie-Charlotte Desseroit3, Omar Miranda4, Philippe Robin5, Pietro Andrea Bonaffini6, Joanne Alfieri7, Ingrid Masson8, Augustin Mervoyer8, Caroline Reinhold6, Olivier Pradier4,3, Mathieu Hatt3, Ulrike Schick4,3. 1. Radiation Oncology Department, University Hospital, Brest, France. francois.lucia@chu-brest.fr. 2. LaTIM, INSERM, UMR 1101, University Brest, Brest, France. francois.lucia@chu-brest.fr. 3. LaTIM, INSERM, UMR 1101, University Brest, Brest, France. 4. Radiation Oncology Department, University Hospital, Brest, France. 5. Nuclear Medicine Department, University Hospital, Brest, France. 6. Department of Radiology, McGill University Health Centre (MUHC), Montreal, Canada. 7. Department of Radiation Oncology, McGill University Health Centre (MUHC), Montreal, Canada. 8. Department of Radiation Oncology, Institut de Cancérologie de l'Ouest, Nantes, France.
Abstract
PURPOSE: The aim of this study was to validate previously developed radiomics models relying on just two radiomics features from 18F-fluorodeoxyglucose positron emission tomography (PET) and magnetic resonance imaging (MRI) images for prediction of disease free survival (DFS) and locoregional control (LRC) in locally advanced cervical cancer (LACC). METHODS: Patients with LACC receiving chemoradiotherapy were enrolled in two French and one Canadian center. Pre-treatment imaging was performed for each patient. Multicentric harmonization of the two radiomics features was performed with the ComBat method. The models for DFS (using the feature from apparent diffusion coefficient (ADC) MRI) and LRC (adding one PET feature to the DFS model) were tuned using one of the French cohorts (n = 112) and applied to the other French (n = 50) and the Canadian (n = 28) external validation cohorts. RESULTS: The DFS model reached an accuracy of 90% (95% CI [79-98%]) (sensitivity 92-93%, specificity 87-89%) in both the French and the Canadian cohorts. The LRC model reached an accuracy of 98% (95% CI [90-99%]) (sensitivity 86%, specificity 100%) in the French cohort and 96% (95% CI [80-99%]) (sensitivity 83%, specificity 100%) in the Canadian cohort. Accuracy was significantly lower without ComBat harmonization (82-85% and 71-86% for DFS and LRC, respectively). The best prediction using standard clinical variables was 56-60% only. CONCLUSIONS: The previously developed PET/MRI radiomics predictive models were successfully validated in two independent external cohorts. A proposed flowchart for improved management of patients based on these models should now be confirmed in future larger prospective studies.
PURPOSE: The aim of this study was to validate previously developed radiomics models relying on just two radiomics features from 18F-fluorodeoxyglucose positron emission tomography (PET) and magnetic resonance imaging (MRI) images for prediction of disease free survival (DFS) and locoregional control (LRC) in locally advanced cervical cancer (LACC). METHODS:Patients with LACC receiving chemoradiotherapy were enrolled in two French and one Canadian center. Pre-treatment imaging was performed for each patient. Multicentric harmonization of the two radiomics features was performed with the ComBat method. The models for DFS (using the feature from apparent diffusion coefficient (ADC) MRI) and LRC (adding one PET feature to the DFS model) were tuned using one of the French cohorts (n = 112) and applied to the other French (n = 50) and the Canadian (n = 28) external validation cohorts. RESULTS: The DFS model reached an accuracy of 90% (95% CI [79-98%]) (sensitivity 92-93%, specificity 87-89%) in both the French and the Canadian cohorts. The LRC model reached an accuracy of 98% (95% CI [90-99%]) (sensitivity 86%, specificity 100%) in the French cohort and 96% (95% CI [80-99%]) (sensitivity 83%, specificity 100%) in the Canadian cohort. Accuracy was significantly lower without ComBat harmonization (82-85% and 71-86% for DFS and LRC, respectively). The best prediction using standard clinical variables was 56-60% only. CONCLUSIONS: The previously developed PET/MRI radiomics predictive models were successfully validated in two independent external cohorts. A proposed flowchart for improved management of patients based on these models should now be confirmed in future larger prospective studies.
Authors: Karen Lim; William Small; Lorraine Portelance; Carien Creutzberg; Ina M Jürgenliemk-Schulz; Arno Mundt; Loren K Mell; Nina Mayr; Akila Viswanathan; Anuja Jhingran; Beth Erickson; Jennifer De los Santos; David Gaffney; Catheryn Yashar; Sushil Beriwal; Aaron Wolfson; Alexandra Taylor; Walter Bosch; Issam El Naqa; Anthony Fyles Journal: Int J Radiat Oncol Biol Phys Date: 2010-05-14 Impact factor: 7.038
Authors: Philippe Lambin; Emmanuel Rios-Velazquez; Ralph Leijenaar; Sara Carvalho; Ruud G P M van Stiphout; Patrick Granton; Catharina M L Zegers; Robert Gillies; Ronald Boellard; André Dekker; Hugo J W L Aerts Journal: Eur J Cancer Date: 2012-01-16 Impact factor: 9.162
Authors: Sonal Kothari; John H Phan; Todd H Stokes; Adeboye O Osunkoya; Andrew N Young; May D Wang Journal: IEEE J Biomed Health Inform Date: 2014-05 Impact factor: 5.772
Authors: Emmanuel Rios Velazquez; Chintan Parmar; Mohammed Jermoumi; Raymond H Mak; Angela van Baardwijk; Fiona M Fennessy; John H Lewis; Dirk De Ruysscher; Ron Kikinis; Philippe Lambin; Hugo J W L Aerts Journal: Sci Rep Date: 2013-12-18 Impact factor: 4.379
Authors: William Rogers; Sithin Thulasi Seetha; Turkey A G Refaee; Relinde I Y Lieverse; Renée W Y Granzier; Abdalla Ibrahim; Simon A Keek; Sebastian Sanduleanu; Sergey P Primakov; Manon P L Beuque; Damiënne Marcus; Alexander M A van der Wiel; Fadila Zerka; Cary J G Oberije; Janita E van Timmeren; Henry C Woodruff; Philippe Lambin Journal: Br J Radiol Date: 2020-02-26 Impact factor: 3.039